FDA Inspection 1175141 — Tarmac Products, Inc.

Tarmac Products, Inc. — FEI 1025483

The FDA completed an inspection of Tarmac Products, Inc. on July 22, 2022 in Miami Gardens, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 22, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Over-the-Counter Drug Evaluation
Location
Miami Gardens, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
356521 CFR 211.58Buildings not maintained in good state of repair
360321 CFR 211.160(b)Scientifically sound laboratory controls
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.